Details for Patent: 11,529,360
✉ Email this page to a colleague
Which drugs does patent 11,529,360 protect, and when does it expire?
Patent 11,529,360 protects BIJUVA and is included in one NDA.
This patent has one hundred and sixty patent family members in twenty-one countries.
Drugs Protected by US Patent 11,529,360
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma | BIJUVA | estradiol; progesterone | CAPSULE;ORAL | 210132-001 | Oct 28, 2018 | RX | Yes | Yes | 11,529,360 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,529,360
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2782584 | ⤷ Subscribe | 301153 | Netherlands | ⤷ Subscribe |
| European Patent Office | 2782584 | ⤷ Subscribe | 2021C/558 | Belgium | ⤷ Subscribe |
| European Patent Office | 2782584 | ⤷ Subscribe | 122021000080 | Germany | ⤷ Subscribe |
| European Patent Office | 2782584 | ⤷ Subscribe | LUC00245 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 2782584 | ⤷ Subscribe | 132021000000197 | Italy | ⤷ Subscribe |
| European Patent Office | 2782584 | ⤷ Subscribe | C202130068 | Spain | ⤷ Subscribe |
| European Patent Office | 2782584 | ⤷ Subscribe | 21C1058 | France | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
